Fig. 2
Cumulative incidence curves from competing risk analyses of first regimen discontinuation for intolerance/toxicity by regimen type
Fig. 2 | AIDS Research and Therapy
Cumulative incidence curves from competing risk analyses of first regimen discontinuation for intolerance/toxicity by regimen type